Human medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma), lonapegsomatropin, Date of authorisation: 11/01/2022, Revision: 7, Status: Authorised

Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (21 August 2026 - 17 September 2026)

Suboxone : EPAR - Procedural steps taken before authorisation

Suboxone : EPAR - Procedural steps taken before authorisation

PSUSA/00010431/202510

Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Date of authorisation: 18/09/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Date of authorisation: 21/09/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Jorveza, budesonide, Date of authorisation: 08/01/2018, Revision: 8, Status: Authorised

Article 57 product data